Granules India gets USFDA nod for pain relief drug
Granules India Ltd announced that the USFDA has approved its Abbreviated New Drug Application (ANDA) for Acetaminophen 650 mg tablets, extended releas18-04-2019
18-04-2019
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Granules India Limited received US FDA aaproval for Acetaminophen 650 mg, Extended Release Tablets18-04-2019
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Pharmaceuticals Inc.received US FDA approval for Acetaminophen 650 mg, Extended Release Tablets18-04-2019
Granules India Ltd - 532482 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 013130 Name of the Signatory :- Chaitanya TummalaDesignation :- Company Secretary and Compliance Officer15-04-2019
Granules India Ltd - 532482 - Compliance Certificate For The Half Year Ended 31St March 2019
Compliance Certificate for the half year ended 31st March 201915-04-2019
Granules India Ltd - 532482 - Submission Of Certificate Under Regulation 40(9) Of SEBI (LODR) Of Regulations 2015.
Regulation 40(10) of SEBI (LODR) of Regulations, 201510-04-2019
GRANULES INDIA LTD.-$ - 532482 - Shareholding for the Period Ended March 31, 2019
Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here05-04-2019
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Intimation Under the SEBI (Phohibition of Insider Trading) Regulations, 201503-04-2019
Granules India Ltd - 532482 - Intimation Of Trading Window Closure
Intimation of Trading Window Closure03-04-2019
Granules India: A pain reliever
Changing product mix and scaling up of capacity should benefit the company30-03-2019